Chart, page-3956

Well agree with the uncertainty in funding but do not agree that they have nothing to show ..they always said that funding would not be required until the second half of 2021, which makes it anytime now..

So anyone expecting funding earlier is just hopes...also impt thing about funding is The EMA trial design is not confirmed and so is the global trial planning and hence what amount is required is unknown even though MD would have everything in his diary right now...but unless confirmation on design parameters come they would not advice us..Also there is a big difference in costs in just Europeand US Europe together ..Also non Dilutive funding will only be revealed after the trial design confirmation ( if there is NDF)..or else good old CR...

IMO